Fexuclu Tablets 40 mg (Fexuprazan Hydrochloride)

Adult dose

Administer 40mg orally once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. This medicine may be administered with or without food.

This medication should not be used in certain patients. Patients who are allergic to this medication or its components or have previously experienced hypersensitivity should not be administered this drug. Additionally, patients taking specific antiviral drugs such as Atazanavir, Nelfinavir, or Rilpivirine should not take this medication. It is also advised that pregnant or breastfeeding women avoid using this drug. Since this medication contains lactose, patients with lactose intolerance or genetic lactose degradation enzyme deficiency should not take it. Patients with liver or kidney function problems, elderly patients, and patients allergic to Yellow No. 4 (Tartrazine) should exercise extra caution when using this medication. Common side effects that may occur while taking this medication include dyspepsia, diarrhea, nausea, abdominal discomfort, chronic gastritis, skin rash or itching, headache, and back pain. Rarely, dizziness, myalgia, cataracts, and runny nose may occur, and patients should consult medical personnel if they experience any abnormal symptoms. This medication reduces stomach acid, which may lead to bacterial growth in the gastrointestinal tract and slightly increase the risk of intestinal infections. Particularly in hospitalized patients, there may be a higher risk of diarrhea due to Clostridium difficile, so if diarrhea persists, it should be reported to medical personnel. Long-term use of this medication may weaken bones and increase the risk of fractures, so patients at risk of osteoporosis should have their condition monitored regularly. Additionally, prolonged use of this medication may lead to decreased serum magnesium levels, which can cause muscle cramps, arrhythmias, and seizures, so regular blood tests are required for those who take it for an extended period or take other medications that can lower magnesium levels. This medication changes gastric acidity and may affect the absorption of other medications; caution is required when taken with certain antiviral drugs. Pregnant or breastfeeding women should not take this medication, and those who are nursing should suspend breastfeeding. Safety and effectiveness in children and adolescents have not been sufficiently established. Elderly patients should be particularly cautious due to the risk of impaired liver or kidney function when using this medication. For patients with impaired renal or liver function, the safety and efficacy of this medication have not been sufficiently validated, so caution is necessary. If this medication is taken in excess, no severe symptoms have been reported, but the patient's condition should be closely monitored, and appropriate treatment should be provided as needed. This medication should be kept out of reach of children and care should be taken not to transfer it to another container, as it may cause accidents or harm the drug's quality.

• dyspepsia
• diarrhea
• nausea
• abdominal discomfort
• chronic gastritis
• gastritis
• erosive gastritis
• erythema
• pruritus
• headache

This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. Storing it this way will safely preserve the effectiveness of the medication.

Appearance

Oval-shaped film-coated tablets in pale green color

Package unit

28 tablets/box [7 tablets/PTP*4], 56 tablets/box [7 tablets/PTP*8], 100 tablets/bottle, 28 tablets/bottle, 300 tablets/bottle, 7 tablets/box [7 tablets/PTP*1], 14 tablets/box [7 tablets/PTP*2]